www.FindFluMist.com

So, what steps can you be taking?

Avoid people who are sick

Cover your mouth and nose when sneezing or coughing

Wash your hands

Avoid touching your eyes, nose or mouth

Disinfect frequently touched surfaces

Above all, the single best way to prevent the flu is to get vaccinated.

The Centers for Disease Control and Prevention recommend getting vaccinated every year against the flu, but did you know that there are several types of flu vaccines to choose from? Better yet, there is a needle-free nasal spray flu vaccine available to eligible patients 2-49 years of age.

Dr. Ravi Jhaveri, Division Head, Infectious Disease; Virginia H. Rogers Professor in Infectious Diseases and Professor of Pediatrics (Infectious Diseases), Northwestern University School of Medicine, will be available to discuss ways to prepare for this year’s flu season including the various types of flu vaccines available.

Interview is courtesy: Interview is courtesy: AstraZeneca

#fluseason #flu #flumist #covid #covid-19 #rsv #holidays #lovedones #illness #nose #eyes #mouth #sneezing #coughing #astrazeneca #drravijhaveri #disease #vaccines

The post FLU SEASON IS HERE, ARE YOU READY?  What you need to know and how to manage the peak of flu season  appeared first on Good News!.

CKD is a progressive condition and patients with CKD have an increased risk of having heart disease.[1][3] However, most patients don’t know they have CKD, in large part because it is a “silent” disease, with most patients feeling no symptoms until the disease has progressed.[4] In fact, while approximately 15% of US adults are living with CKD, 9 in 10 are unaware they have CKD.[1]

Now, a new treatment option has been proven to help slow the progression of CKD – a huge scientific innovation for CKD patients at risk of progression with and without T2D. This approval is the most significant advancement in the treatment of CKD in over 20 years.

Because CKD may be overlooked until symptoms appear at advanced stages, it is especially important to be aware of risk factors and the serious complications that can occur.[1][5]

CKD tends to get worse over time, so the earlier treatment starts, the better the patient outcomes are. [3]

On May 19, Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, will be available to discuss the latest treatment option approved by the FDA. Dr. Skolnik will also discuss risk factors and the importance of early detection of CKD.

Interview Courtesy: AstraZeneca

1. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2019. https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html.

2. AstraZeneca. Diagnose CKD Now. https://www.diagnoseckdnow.com/

3. Centers for Disease Control and Prevention. Chronic Kidney Disease Basics. www.cdc.gov/kidneydisease/basics.html.

4. National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Disease Statistics for the United States. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease.

5. National Kidney Foundation. Estimated Glomerular Filtration Rate (Egfr). https://www.kidney.org/content/gfr]

#astrazeneca #farxiga #kidney #disease #health #chronic #patient #risk #diabetes #treatment #therapy #heart #ckd #neil #skolnik #thomas #jefferson #medicine #medical #family #factors

The post THE FIRST MAJOR DEVELOPMENT IN 20 YEARS TO HELP MANAGE CHRONIC KIDNEY DISEASE IN PATIENTS AT RISK OF PROGRESSION WITH AND WITHOUT TYPE 2 DIABETES appeared first on Good News!.

As COVID-19 Cases Continue to Increase in Many US States, Doctors Are Looking to Prepare
Families for What They Can Better Control – The Seasonal Flu

PrepareforFlu.com

While the number of people infected by the flu each year fluctuates based on a variety of factors such as virus strains and characteristics of the person being vaccinated, the CDC findings suggest that about 8% of the United States population contracts symptomatic flu illness every year. However, this flu season will be different than those of the past, as this year the US is also navigating the COVID-19 pandemic.

Many questions and anxieties remain surrounding the global pandemic, including when a vaccine will be available, whether a second wave is coming, or even when the first wave will end. Amid increased uncertainty, and as a result of the impacts of both the flu and COVID-19, doctors are actively preparing their communities to help stay protected and healthy.

This year, an important action that parents can take for their families is to talk to a healthcare provider about getting a flu vaccine. In fact, the CDC is encouraging flu vaccination for the upcoming season, now more than ever, to help reduce the burden on the healthcare system. While some people regularly get a flu vaccine, others do not. There are several vaccine options available, even for those who prefer a needle-free option. The CDC does not recommend one flu vaccine over another. It is important to speak to your healthcare provider to determine which vaccine is right for you and your loved ones.

Dr. Ravi Jhaveri, MD, Associate Division Head of Pediatric Infectious Diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago and Professor of Pediatrics at Northwestern University Feinberg School of Medicine will discuss how parents can prepare their families for this year’s flu season, while navigating alongside a global pandemic.

Interview courtesy: AstraZeneca

#dr #ravi #jhaveri astrazeneca #md #associate #division #head #pediatric #infectious #diseases #disease #ann #robert #lurie #children #hospital #chicago #northwestern #university #feinberg #school #medicine #families #family #flu #season #global #pandemic #covid #covid19 #codvid-19 #us #states #doctors #increase #control #fluctuates #vaccine #virus #cdc #impact #healthcare

The post EASING ANXIETIES ABOUT THE UPCOMING FLU SEASON WHILE THE COVID-19 PANDEMIC CONTINUES appeared first on Good News!.

NEW RESEARCH FROM PROMINENT CANCER MEETING FOR THOSE WITH LUNG CANCER

People with Lung Cancer, Like Others with Serious Underlying Medical Conditions
Might Be at an Increased Risk for Severe Illness from COVID-19

Lung cancer is the second most common cancer in both men and women. This year, an estimated 228,820 adults (116,300 men and 112,520 women) in the United States will be diagnosed.

The fight against lung cancer continues with new research and scientific advances, including cancer experts investigating potential ways to treat the disease in earlier stages. Some of these latest findings in non-small cell lung cancer (NSCLC), including investigational studies in earlier stages of the disease, were presented at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program.

Roy S. Herbst, MD, PhD of Yale Cancer Center and Smilow Cancer Hospital talks on the latest news from ASCO in the fight against lung cancer.

Lung cancer makes up almost 25% of all cancer deaths. There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common type of lung cancer. In fact, about 80%-85% of lung cancer cases are NSCLC. About 40% of patients are diagnosed at a later stage of disease, such as Stage IV, when the cancer has progressed to other organs. Approximately 10-15% of NSCLC patients in the US and Europe, and 30-40% of patients in Asia have EGFRm NSCLC. The prevalence of EGFR mutations in early stage are estimated to be ~33% in a global NSCLC population.

Interview courtesy: AstraZeneca
#roy #harbst #yale #cancer #center #smilow #covid-19 #covid #19 #covid19 #lung #severe #illness #medical #risk #diagnosed #research #scientific #advances #disease #cell #nsclc #american #society #clinical #oncology #asco #virtual #hospital #astrazeneca

The post NEW RESEARCH FOR LUNG CANCER appeared first on Good News!.